当代乳腺癌放疗侧别与冠状动脉疾病风险增加无关
该研究通过荟萃分析(9项研究)和机构队列(2010-2022年高危心血管患者)评估乳腺癌放疗侧别与冠状动脉疾病(CAD)风险的关系。荟萃分析显示左侧放疗患者CAD风险较右侧增加10%(RR=1.10,95%CI 1.02-1.18,P=0.01),但1980年后诊断的6项研究亚组分析无显著差异(RR=1.07,95%CI 0.95-1.20,P=0.27);机构队列中左侧与右侧相比无显著差异(HR=0.73,95%CI 0.34-1.54,P=0.402)。结论提示历史趋势存在,但现代放疗方案安全,短期内心脏侧别不影响CAD结局。
要点
- 荟萃分析9项研究显示左侧乳腺癌放疗患者CAD风险较右侧增加10%(RR=1.10,95%CI 1.02-1.18,P=0.01)。
- 1980年后诊断的6项研究亚组分析未显示侧别与CAD风险显著相关(RR=1.07,95%CI 0.95-1.20,P=0.27)。
- 机构队列中左侧与右侧乳腺癌放疗患者CAD风险无显著差异(HR=0.73,95%CI 0.34-1.54,P=0.402)。
核心结论
- 研究提示乳腺癌左侧放疗患者CAD风险增加为历史趋势,现代放疗方案安全,短期内心脏侧别不影响CAD结局。
研究设计与样本
- 荟萃分析检索PubMed、Web of Science和Scopus,纳入1999年1月至2022年9月的研究,采用随机效应模型计算风险比(RR)。
- 机构队列部分选取2010年至2022年诊断的高心血管风险乳腺癌患者,采用Cox比例风险模型逐步调整。
主要发现
- 9项研究的荟萃分析显示左侧乳腺癌放疗患者CAD风险较右侧增加10%(RR=1.10,95%CI 1.02-1.18,P=0.01)。
- 6项1980年后诊断患者的亚组分析未显示CAD风险基于侧别的显著差异(RR=1.07,95%CI 0.95-1.20,P=0.27)。
- 机构队列中左侧乳腺癌放疗患者CAD风险与右侧相比无显著差异(HR=0.73,95%CI 0.34-1.54,P=0.402)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: External beam radiation therapy (EBRT) is a critical component of breast cancer (BC) therapy. Given the improvement in technology in the contemporary era, we hypothesized that there is no difference in the development of or worsening of existing coronary artery disease (CAD) in patients with BC receiving left versus right-sided radiation. METHODS AND MATERIALS: For the meta-analysis portion of our study, we searched PubMed, Web of Science, and Scopus and included studies from January 1999 to September 2022. CAD was identified using a homogenous metric across multiple studies included. We computed the risk ratio (RR) for included studies using a random effects model. For the institutional cohort portion of our study, we selected high cardiovascular-risk patients who received diagnoses of BC between 2010 and 2022 if they met our inclusion criteria. We performed a Cox proportional hazards model with stepwise adjustment. RESULTS: A pooled random effects model with 9 studies showed that patients with left-sided BC receiving EBRT had a 10% increased risk of CAD when compared with patients with right-sided BC receiving EBRT (RR, 1.10; 95% CI, 1.02-1.18; P = .01). However, subgroup analysis of 6 studies that included patients diagnosed after 1980 did not show a significant difference in CAD based on BC laterality (RR, 1.07; 95% CI, 0.95-1.20; P = .27). For the institutional cohort portion of the study, we found that patients with left-sided BC who received EBRT did not have a significantly higher risk of CAD when compared with their right-sided counterparts (hazard ratios [HR], 0.73; 95% CI, 0.34-1.54; P = .402). CONCLUSIONS: Our study suggests a historical trend of increased CAD in BC patients receiving left-sided EBRT. Data from patients diagnosed after 2010 in our institutional cohort did not show a significant difference, emphasizing that modern EBRT regimens are safe, and laterality of BC does not affect CAD outcomes in the short term after a BC diagnosis.
引用
- Seth L, Makram O, Essa A, et al. Laterality of Radiation Therapy in Breast Cancer is Not Associated With Increased Risk of Coronary Artery Disease in the Contemporary Era. Adv Radiat Oncol. 2024. PMID: 39258143. doi:10.1016/j.adro.2024.101583
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。